VITALEÖNBIOSCIENCES Cart 0

Ipamorelin: Selective GH Release, Human Pharmacology and Open Questions

Ipamorelin: Selective GH Release, Human Pharmacology and Open Questions

Ipamorelin is a synthetic growth-hormone secretagogue that acts through the ghrelin receptor. It was developed for relative selectivity toward GH release, but the human evidence base is much narrower than online claims often suggest.

What “selective” means in the early research

Preclinical experiments compared ipamorelin with other growth-hormone-releasing peptides and reported GH release with less stimulation of ACTH and cortisol in the tested models. Selectivity is relative, depends on experimental conditions and does not itself establish clinical safety.

Human pharmacology

A dose-escalation study in healthy male volunteers measured circulating ipamorelin and GH after short intravenous infusions. Exposure was dose-proportional, the reported terminal half-life was approximately two hours, and GH rose as a single peak before declining. This was a pharmacokinetic and pharmacodynamic experiment, not a trial of muscle gain, recovery or body composition.

A later clinical test

A randomized phase-2 proof-of-concept study evaluated ipamorelin as a ghrelin-receptor agonist for postoperative ileus. The study is important because it tested a defined clinical endpoint rather than hormone release alone; its findings should not be repurposed as evidence for unrelated performance or wellness claims.

What remains unknown

There is insufficient controlled evidence for long-term use, body-composition outcomes, athletic recovery or anti-aging effects in healthy people. Product identity and purity are also crucial because a research material is not equivalent to the regulated formulation used in a trial.

Selected primary sources

Image: authentic pituitary-gland histology by Athikhun Suw, Wikimedia Commons, CC BY-SA 4.0. Educational research content only; not medical advice or a treatment recommendation.

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *